This topic contains a solution. Click here to go to the answer

Author Question: The difference between males and females in relative risk for developing major depressive ... (Read 69 times)

karen

  • Hero Member
  • *****
  • Posts: 537
The difference between males and females in relative risk for developing major depressive
   disorder begins in ______.
 
  a. childhood c. young adulthood
   b. adolescence d. middle age

Question 2

Mowrer's two-factor model assumes that the avoidance component of phobias is acquired and
   maintained through ______.
 
  a. positive reinforcement c. punishment
   b. aversive conditioning d. negative reinforcement



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Chelseyj.hasty

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

B

Answer to Question 2

D




karen

  • Member
  • Posts: 537
Reply 2 on: Jun 22, 2018
:D TYSM


bimper21

  • Member
  • Posts: 309
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

Carbamazepine can interfere with the results of home pregnancy tests. If you are taking carbamazepine, do not try to test for pregnancy at home.

Did you know?

The average human gut is home to perhaps 500 to 1,000 different species of bacteria.

Did you know?

Historic treatments for rheumatoid arthritis have included gold salts, acupuncture, a diet consisting of apples or rhubarb, nutmeg, nettles, bee venom, bracelets made of copper, prayer, rest, tooth extractions, fasting, honey, vitamins, insulin, snow collected on Christmas, magnets, and electric convulsion therapy.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library